Livestock Vaccines Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	150 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224133

Best Price Guarantee
Price	from $4,850
Length	150 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224133

Livestock Vaccines Market

Growth Factors of Livestock Vaccines Market

The global livestock vaccines market size was valued at USD 5.73 billion in 2023 and is projected to grow from USD 6.01 billion in 2024 to USD 9.80 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period of 2024-2032.

However, the COVID-19 outbreak affected the production and supply of farm animal vaccines, focusing on zoonotic diseases further, revitalizing the emphasis on animal fitness, and accelerating market recovery, which hindered the livestock vaccines market growth.

The market for cattle vaccines is growing due to the increase in demand for meal merchandise from animals, increasing frequency of poverty among farm animals, augmented awareness of the health of animals, and initiatives given by the governments to encourage vaccines for stopping diseases amongst farm animals.

Personalized vaccines are a growing fashion within the cattle vaccines market. Advancements in the vaccine era enable the improvement of vaccines tailored to unique pathogens or animal genotypes, imparting more excellent robust safety in opposition to sicknesses and expanding the livestock vaccines market share globally. By concentrating on particular ailment editions or individual animal traits, personalized vaccines can offer a more custom-designed and effective ailment prevention technique, contributing to livestock populations' general fitness and well-being.

Comprehensive Analysis of Livestock Vaccines Market

The livestock vaccines market is segmented by kind, animal type, direction of administration, and distribution channel. The stay attenuated vaccines section led to growing disorder outbreaks and robust immune responses. The bovine phase is dominated by animal type, while the fowl segment is predicted to increase. Parenteral management has turned into the leading direction because of its reliability, with oral administration showing a sturdy boom potential. Veterinary clinics held the most crucial distribution channel share, supported via improved animal visits and vaccine adoption, while veterinary hospitals are also anticipated to see a considerable increase.

The North America region led the livestock vaccines market by benefitting a size of USD 2.68 billion in 2023 due to the growth in vaccine launches through marketplace players, the area is anticipated to dominate the global market percentage.

The leading livestock vaccine market players significantly shape its growth trajectory and set industry standards. Key companies, including Boehringer Ingelheim International GmbH (Germany), Virbac (France), Merck Animal Health (Merck & Co., Inc.) (U.S.), Zoetis Services LLC (U.S.), Ceva (France), Elanco (U.S.), HIPRA (Spain), and Neogen Corporation (U.S.), contribute to a highly competitive landscape, driving innovation and market development.

In December 2023, The private limited chain subsidiary of the NDDB, Indian Immunologicals Ltd (IIL), found that its most promising innovative vaccines in the pipeline are for the IBR ache and lumpy skin disease in conjunction with an advocacy mixture for rabies prevention.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 6.3% from 2024-2032

Unit Value (USD billion)

Segmentation

By Type

Inactivated
Live Attenuated
Recombinant
Others

By Animal Type

Bovine
Swine/ Porcine
Poultry
Others

By Route of Administration

Oral
Parenteral
Others

By Distribution Channel

Veterinary Hospitals
Veterinary Clinics
Others

By Geography

North America (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country)
U.S.
Canada
Europe (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
U.K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe
Asia Pacific (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
China
India
Japan
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region
Brazil
Mexico
Rest of the Latin America
Middle East & Africa (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
GCC
South Africa
Rest of the Middle East & Africa

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Veterinary Vaccination Rates: Key Conditions; 4.2. Overview on Vaccination Programs; 4.3. Key Industry Developments, Mergers, Acquisitions, Partnerships, etc.; 4.4. Impact of COVID-19 Pandemic on Livestock Vaccines Market
5. Global Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Type; 5.1.1. Inactivated; 5.1.2. Live Attenuated; 5.1.3. Recombinant; 5.1.4. Others; 5.2. Market Analysis, Insights and Forecast – By Animal Type; 5.2.1. Bovine; 5.2.2. Swine/ Porcine; 5.2.3. Poultry; 5.2.4. Others; 5.3. Market Analysis, Insights and Forecast – By Route of Administration; 5.3.1. Oral; 5.3.2. Parenteral; 5.3.3. Others; 5.4. Market Analysis, Insights and Forecast – By Distribution Channel; 5.4.1. Veterinary Hospitals; 5.4.2. Veterinary Clinics; 5.4.3. Others; 5.5. Market Analysis, Insights and Forecast – By Region; 5.5.1. North America; 5.5.2. Europe; 5.5.3. Asia Pacific; 5.5.4. Latin America; 5.5.5. Middle East & Africa
6. North America Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Type; 6.1.1. Inactivated; 6.1.2. Live Attenuated; 6.1.3. Recombinant; 6.1.4. Others; 6.2. Market Analysis, Insights and Forecast – By Animal Type; 6.2.1. Bovine; 6.2.2. Swine/ Porcine; 6.2.3. Poultry; 6.2.4. Others; 6.3. Market Analysis, Insights and Forecast – By Route of Administration; 6.3.1. Oral; 6.3.2. Parenteral; 6.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By Distribution Channel; 6.4.1. Veterinary Hospitals; 6.4.2. Veterinary Clinics; 6.4.3. Others; 6.5. Market Analysis, Insights and Forecast – By Country; 6.5.1. U.S.; 6.5.2. Canada
7. Europe Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Type; 7.1.1. Inactivated; 7.1.2. Live Attenuated; 7.1.3. Recombinant; 7.1.4. Others; 7.2. Market Analysis, Insights and Forecast – By Animal Type; 7.2.1. Bovine; 7.2.2. Swine/ Porcine; 7.2.3. Poultry; 7.2.4. Others; 7.3. Market Analysis, Insights and Forecast – By Route of Administration; 7.3.1. Oral; 7.3.2. Parenteral; 7.3.3. Others; 7.4. Market Analysis, Insights and Forecast – By Distribution Channel; 7.4.1. Veterinary Hospitals; 7.4.2. Veterinary Clinics; 7.4.3. Others; 7.5. Market Analysis, Insights and Forecast – By Country/Sub-region; 7.5.1. United Kingdom; 7.5.2. Germany; 7.5.3. France; 7.5.4. Spain; 7.5.5. Italy; 7.5.6. Scandinavia; 7.5.7. Rest of Europe
8. Asia Pacific Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Type; 8.1.1. Inactivated; 8.1.2. Live Attenuated; 8.1.3. Recombinant; 8.1.4. Others; 8.2. Market Analysis, Insights and Forecast – By Animal Type; 8.2.1. Bovine; 8.2.2. Swine/ Porcine; 8.2.3. Poultry; 8.2.4. Others; 8.3. Market Analysis, Insights and Forecast – By Route of Administration; 8.3.1. Oral; 8.3.2. Parenteral; 8.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By Distribution Channel; 8.4.1. Veterinary Hospitals; 8.4.2. Veterinary Clinics; 8.4.3. Others; 8.5. Market Analysis, Insights and Forecast – By Country/Sub-region; 8.5.1. China; 8.5.2. India; 8.5.3. Japan; 8.5.4. Australia; 8.5.5. Southeast Asia; 8.5.6. Rest of Asia Pacific
9. Latin America Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Type; 9.1.1. Inactivated; 9.1.2. Live Attenuated; 9.1.3. Recombinant; 9.1.4. Others; 9.2. Market Analysis, Insights and Forecast – By Animal Type; 9.2.1. Bovine; 9.2.2. Swine/ Porcine; 9.2.3. Poultry; 9.2.4. Others; 9.3. Market Analysis, Insights and Forecast – By Route of Administration; 9.3.1. Oral; 9.3.2. Parenteral; 9.4. Market Analysis, Insights and Forecast – By Distribution Channel; 9.4.1. Veterinary Hospitals; 9.4.2. Veterinary Clinics; 9.4.3. Others; 9.5. Market Analysis, Insights and Forecast – By Country/Sub-region; 9.5.1. Brazil; 9.5.2. Mexico; 9.5.3. Rest of Latin America
10. Middle East & Africa Livestock Vaccines Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Type; 10.1.1. Inactivated; 10.1.2. Live Attenuated; 10.1.3. Recombinant; 10.1.4. Others; 10.2. Market Analysis, Insights and Forecast – By Animal Type; 10.2.1. Bovine; 10.2.2. Swine/ Porcine; 10.2.3. Poultry; 10.2.4. Others; 10.3. Market Analysis, Insights and Forecast – By Route of Administration; 10.3.1. Oral; 10.3.2. Parenteral; 10.4. Market Analysis, Insights and Forecast – By Distribution Channel; 10.4.1. Veterinary Hospitals; 10.4.2. Veterinary Clinics; 10.4.3. Others; 10.5. Market Analysis, Insights and Forecast – By Country/Sub-region; 10.5.1. South Africa; 10.5.2. GCC; 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Boehringer Ingelheim International GmbH; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Virbac; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Merck Animal Health (Merck & Co., Inc.); 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. Zoetis Services LLC; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Ceva; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Elanco; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. Nisseiken Co., Ltd.; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. Neogen Corporation; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability)